(Q46781766)
Statements
Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group (English)
Manfred Kaufmann
Erika Graf
Walter Jonat
Wolfgang Eiermann
Matthias Geberth
Ute-Susann Albert
Günther Gademann
Bettina Conrad
Karin Stahl
Martin Schumacher
German Adjuvant Breast Cancer Group